n addition to the award, BIH is seeking to promote networking and joint projects between the laureate and scientists in the translational research commons of Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC). For this reason, BIH may nominate laureates as an Einstein BIH Visiting Fellow or a BIH Visiting Professor at Stiftung Charité if he or she meets all further requirements.
Sex and gender aspects must be a fundamental part of the applicant’s research approach or study design. Scientists must apply by October 15, 2017. The winner will be selected by an international panel of experts from the field of gender medicine. You can find detailed information on the award and the application process at www.bihealth.org/en/award.